莫氏手术时非黑素瘤皮肤癌组织病理学升级的前瞻性研究
这项前瞻性横断面研究在1年内筛查接受莫氏显微手术(MMS)的非黑素瘤皮肤癌(NMSC)患者,由2名经过专科培训的莫氏手术医生独立复核冰冻切片。2578个肿瘤中265个(10.3%)在手术时冰冻切片分析中显示比初始活检更具侵袭性的组织学亚型。升级肿瘤需要更多手术阶段才能达到肿瘤清除,术后缺损更大,且更常需要复杂修复。
要点
- 10.3%的非黑素瘤皮肤癌在莫氏手术时组织学升级为更具侵袭性亚型。
- 升级肿瘤需要更多手术阶段、更大术后缺损且更常需复杂修复。
- 该发现对皮肤科医生的转诊实践和莫氏手术适当使用标准有重要意义。
核心结论
- 相当一部分莫氏手术病例在手术时组织学升级为比初始活检更具侵袭性的亚型。
- 升级病例比非升级病例更大且手术更具挑战性。
研究设计与样本
- 前瞻性横断面研究,筛查1年内在本机构接受莫氏显微手术治疗非黑素瘤皮肤癌的所有患者。
- 冰冻切片由2名经过专科培训的莫氏手术医生独立复核。
主要发现
- 2578个肿瘤中265个(10.3%)在手术时冰冻切片分析中显示比初始活检更具侵袭性的皮肤癌组织学亚型。
- 升级肿瘤需要显著更多手术阶段才能达到肿瘤清除,术后缺损尺寸更大,且更常需要复杂修复。
临床怎么用
- 提示原发皮肤科医生转诊时应考虑初始活检可能低估组织学侵袭性。
- 对莫氏手术适当使用标准指南具有参考意义。
局限性
- 单中心研究。
- 研究时间有限。
- 横断面设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anecdotal experience and data from multiple retrospective studies have suggested that a significant percentage of nonmelanoma skin cancers (NMSCs) display an aggressive histologic subtype that is not diagnosed on initial biopsy. OBJECTIVE: To prospectively determine the proportion of NMSCs upgraded at the time of Mohs micrographic surgery (MMS) and examine the surgical parameters of upgraded lesions. METHODS: In this prospective, cross-sectional study, all patients undergoing MMS for NMSC at our institution over the course of 1 year were screened for inclusion. Frozen sections were reviewed independently by 2 fellowship-trained Mohs surgeons. RESULTS: In total, 265 of 2578 (10.3%) tumors displayed a more aggressive skin cancer histologic subtype on frozen-section analysis at the time of surgery than at the initial biopsy. Upgraded tumors required significantly more stages to reach tumor clearance, had a larger postoperative defect size, and more often required complicated repairs than nonupgraded tumors. LIMITATIONS: Single center study, limited time period, and cross-sectional design. CONCLUSION: A significant portion of MMS cases were upgraded at the time of surgery to a more aggressive subtype than that seen at the initial biopsy. Upgraded cases were larger and more surgically challenging than nonupgraded ones. This finding has important implications for primary dermatologists' referral practices and Mohs appropriate use criteria guidelines.
引用
- Kyllo RL, Staser KW, Rosman I, et al. Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective review. J Am Acad Dermatol. 2019. PMID: 31230975. doi:10.1016/j.jaad.2019.02.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。